SCHEMBL3034002

SCHEMBL3034002

Brc1cccc(COc2ccc(CN3CCC3)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
TDP1 Q9NUW8 1/20 0.61
MAOB P27338 3/20 0.56
CA12 O43570 1/20 0.54
CA9 Q16790 1/20 0.54
NPC1 O15118 3/20 0.53
TP53 P04637 2/20 0.53
RAB9A P51151 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
KMT2A Q03164 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
FFAR1 O14842 1/20 0.53
FFAR4 Q5NUL3 1/20 0.53
PARP15 Q460N3 1/20 0.52
PARP14 Q460N5 1/20 0.52
PARP10 Q53GL7 1/20 0.52
MAOA P21397 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21348251 0.97 HRH3 (0.66) HRH3SMN1; SMN2TDP1MAOBCA12
SCHEMBL3044721 0.84 MAOB (0.64) HRH3SMN1; SMN2MAOBNPC1TP53
SCHEMBL3038005 0.84 HRH3 (0.77) HRH3NPC1TP53RAB9A
SCHEMBL28255630 0.83 HRH3 (0.66) HRH3SMN1; SMN2MAOBNPC1TP53
SCHEMBL31484892 0.82 HRH3 (0.78) HRH3SMN1; SMN2NPC1TP53RAB9A
SCHEMBL21347483 0.82 HRH3 (0.68) HRH3SMN1; SMN2MAOBNPC1TP53
SCHEMBL6057451 0.81 HRH3 (0.82) HRH3
SCHEMBL7811609 0.81 NPC1 (0.78) HRH3SMN1; SMN2NPC1TP53RAB9A
SCHEMBL21348314 0.81 HRH3 (0.70) HRH3SMN1; SMN2NPC1TP53RAB9A
SCHEMBL21347499 0.81 HRH3 (0.66) HRH3SMN1; SMN2MAOBALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108912029-A Nitrogen-containing heterocycle amide derivatives and application thereof 广东东阳光药业有限公司 2018-11-30 CN disclosed
US-20100216762-A1 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof ABBOTT LABORATORIES (US) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216762-A1 Agonists and Antagonists of the S1P5 Receptor, and Methods of Use Thereof S1PR5, LPAR5, S1PR1 HRH3 469/4885SMN1; SMN2 148/4885TDP1 1587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.